Phase II trial of indolepropionic acid in patients with Alzheimer's disease.
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2010
At a glance
- Drugs Indolepropionic acid (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Therapeutic Use
- Sponsors Intellect Neurosciences
- 05 Dec 2008 New trial record.